Skip to main content
Signal8

McCourt Marion

SEC insider (Form 3/4/5 filer). CIK 0001663758. EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN). 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in TARRYTOWN, NY.

Companies McCourt Marion has filed insider reports for

  • REGENERON PHARMACEUTICALS, INC. (REGN): Officer, EVP Commercial
McCourt Marion profile photo

McCourt Marion

CIK: 0001663758

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (35.7%)

Position reduction

Option Exercises (M)3 (21.4%)

Derivative conversions

Awards (A)2 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REGENERON PHARMACEUTICALS, INC. logo
REGN

REGENERON PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Sep 3, 2026
    Sale
    Direct
    1.1K shares at avg. $857.39$970K
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Sep 2, 2026
    Sale
    Direct
    1.2K shares at avg. $850.00$1.0M
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 9, 2025
    Tax Payment
    Direct
    1K shares at avg. $701.51$716K
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 8, 2025
    Tax Payment
    Direct
    1.3K shares at avg. $712.94$952K
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 5, 2025
    Award
    Direct
    2.5K shares-
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 16, 2024
    Tax Payment
    Direct
    759 shares at avg. $730.81$555K
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 9, 2024
    Tax Payment
    Direct
    274 shares at avg. $787.00$216K
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Dec 6, 2024
    Award
    Direct
    2.3K shares-
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Nov 1, 2024
    Exercise
    Direct
    1K shares at avg. $381.40$381K
  • REGENERON PHARMACEUTICALS, INC. logo
    REGN

    REGENERON PHARMACEUTICALS, INC.

    Nov 1, 2024
    Sale
    Direct
    1K shares at avg. $844.61$845K

1-10 of 14